Inventor · disambiguated record
Matthew Mahoney
Also filed as: MAHONEY MATTHEW · MAHONEY MATTHEW W · MAHONEY MATTHEW WILLIAM
13 granted patents·13 pending applications·31 citations·filing 2000–2019
88Inventor score
Top patents by PatentIndex Score
26 records- 0196US9011832B2Heteroatom containing cyclic dimersNOVUS INT INC·Filed 2013·Granted Apr 21, 2015·10 cites·30 claims
- 0291US9410036B2Functionalized polymer compositionsNOVUS INT INC·Filed 2016·Granted Aug 9, 2016·2 cites·17 claims
- 0390US9447068B2Functionalized polymer compositionsNOVUS INT INC·Filed 2015·Granted Sep 20, 2016·2 cites·19 claims
- 0488US9284294B2Functionalized polymer compositionsNOVUS INT INC·Filed 2013·Granted Mar 15, 2016·3 cites·34 claims
- 0587US10106496B2Hydroxy methionine analog formulations suitable for specialty chemical applicationsNOVUS INT INC·Filed 2017·Granted Oct 23, 2018·1 cites·24 claims
- 0682US9801845B2Antimicrobial compositions and uses thereofNOVUS INT INC·Filed 2016·Granted Oct 31, 2017·2 cites·22 claims
- 0779US6664255B1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Dec 16, 2003·7 cites·27 claims
- 0867US10457660B2Heteroatom containing cyclic dimersNOVUS INT INC·Filed 2015·Granted Oct 29, 2019·0 cites·31 claims
- 0967US10240029B2Plastic modifiersNOVUS INT INC·Filed 2016·Granted Mar 26, 2019·0 cites·23 claims
- 1065US6908919B2Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Jun 21, 2005·3 cites·27 claims
- 1164US2005143371A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1264US2019169399A1Plastic modifiersNOVUS INT INC·Filed 2019·Application pending·0 cites
- 1363US2005137220A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1463US2017107192A1Heteroatom containing cyclic dimersNOVUS INT INC·Filed 2016·Application pending·0 cites
- 1561US8097733B2Pyrazole derivatives as 5-LO-inhibitorsALVIRA EDGARDO·Filed 2008·Granted Jan 17, 2012·1 cites·5 claims
- 1661US2019016675A1Hydroxy methionine analog formulations suitable for specialty chemical applicationsNOVUS INT INC·Filed 2018·Application pending·0 cites
- 1759US11185524B2Means for protecting methionine hydroxy analog from rumen degradationNOVUS INT INC·Filed 2019·Granted Nov 30, 2021·0 cites·15 claims
- 1853US2004209897A1Mitogen activated protein kinase-activated protein kinase-2 inhibiting compoundsPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1952US2012035131A1Pyrazoline compoundsMEYERS MARVIN J·Filed 2011·Application pending·0 cites
- 2052US2020060273A1Fungicidal compositionsNOVUS INT INC·Filed 2018·Application pending·0 cites
- 2152US2005101623A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2249US2010280016A1Pyrazoline compoundsPFIZER·Filed 2010·Application pending·0 cites
- 2348US2005043313A1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2448US2004102448A1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2537US2017298006A1Substituted 1,2-dihydroquinolines with low contaminant levels and processes for preparingNOVUS INT INC·Filed 2017·Application pending·0 cites
- 2636US7119094B1Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascadeWARNER LAMBERT CO·Filed 2000·Granted Oct 10, 2006·0 cites·46 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →